Axxess Pharma
Markham
About Axxess Pharma
Axxess Pharma Inc., a pharmaceutical company, engages in the marketing and distribution of various pharmaceutical products and diagnostic medical devices in Canada and internationally. The company distributes dermatological, therapeutic nutritional, pain management, and diagnostic products. Its principal product line includes Britical, Gravergol, Lactrase, Somnol, Triferexx, Urasal, Axspaz, Vivol, Hydraxx, Kemsol, Soropon, Amersol, Bactalase, Monurol, and Zynol, as well as skin care products. Axxess Pharma Inc. distributes its products through physicians, hospitals, government and defense institutions, and pharmacies. The company was founded in 1997 and is headquartered in Markham, Canada.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Last round: Series Unknown (Jul 2014)
- Website: axxesspharma.com
- Phone: 905-513-0000
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/axxess-pharma-1412565 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.